Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2018, 27(1):20-26

Assessment of left ventricular arrhythmogenic substrate in patients with ischemic heart disease by cardiac magnetic resonance

Neuschl V1, Berecova Z2, Madaric J3, Simkova J1, Glezlova A1, Hatala R3
1 Institute of Diagnostic Imaging, MRI s.r.o., Trnava
2 Department of radiology, St. Michal Hospital, Bratislava
3 Department of Arrhythmias and Cardiac Pacing, Academic Divsion of Cardiology and Angiology, Medical Faculty, Slovak Medical University and National Cardiovascular Institute - NUSCH Bratislava, Slovakia

Background: The most common cause of sudden death is malignant ventricular tachyarrhythmia - ventricular tachycardia and ventricular fibrillation occurring based on the morphological substrate of the infarction scar.

Objectives: Results of qualitative and quantitative analysis of the scar and LV (left ventricular) function acquired by cardiac magnetic resonance (CMR) were correlated with the subsequent occurrence of malignant ventricular arrhythmias in patients with a high risk of sudden cardiac death (SCD).

Methods: We have prospectively followed 47 patients (mean age 60 ± 11 years) who were hospitalized for an implantable cardioverter-defibrillator (ICD) implantation to prevent SCD. All post-myocardial infarction (post-MI) patients had severe residual LV dysfunction (LVEF 33±14%). Patients were examined by CMR. In the CMR analysis, we evaluated the basic functional parameters of the LV as well as the mass, volume, transmurality and heterogeneity of the post-MI scar.

Results: The patients with malignant arrhythmias were characterized by smaller LV diameters in the enddiastole (LVED 192 ± 79 vs. 254 ± 47 mm, p = 0.003) and end-systole (LVES 131 ± 80 vs. 181 ± 45 mm, p = 0.01). As for the other observed functional and morphological CMR parameters, no significant differences between the two groups were detected.

Conclusion: These results indicate that post-MI patients with severe residual left ventricular dysfunction and dilatation are in the long-term characterized by a lower incidence of malignant arrhythmias compared to the patients with less dilated LV with a comparably severe LV dysfunction. Fig. 3, Tab. 2, Ref. 24, online full text (Free, PDF), www.cardiologyletters.sk Primárna práca bola uverejnená v: Neuschl V, Berecova Z, Madaric J, Simkova J, Glezlova A, Hatala R. Structural assessment of myocardial infarction scars and left ventricular function wit cardiac magnetic resonance imaging in patients with high risk of sudden cardiac death. Bratisl Med J 2018;119(5), in press.

Keywords: myocardial infarction; cardiac magnetic resonance imaging; ventricular tachyarrhythmias sudden cardiac death; implantable cardioverter defibrillator

Published: January 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Neuschl V, Berecova Z, Madaric J, Simkova J, Glezlova A, Hatala R. Assessment of left ventricular arrhythmogenic substrate in patients with ischemic heart disease by cardiac magnetic resonance. Cardiology Letters. 2018;27(1):20-26.
Download citation

References

  1. Mozaffarian D, Benjamin EJ, Go AS, et al. 2015 Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322. doi: 10.1161/CIR.00000000000001 Go to original source...
  2. Gräsner JT, Lefering R, Koster RW, et al. EuReCa ONE-27 Nations, ONE Europe, ONE Registry: A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe. Resuscitation. 2016 Aug;105:188-195. doi: 10.1016/j.resuscitation.2016.06.004 Go to original source...
  3. Bayés De Luna A, Coumel P, Leclercq JF. 1989. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151-159. Go to original source...
  4. Priori SD, Blomström-Lundquist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J. 2015;1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Go to original source...
  5. Dagres N, Hindricks G. 2013 Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? Eur Heart J. 2013;34:1964-1971. Go to original source...
  6. Fernández-Armenta J, Berruezo A, Mont L, et al. 2012. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy. Europace. 2012;14:15781586. doi:10.1093/europace/eus104 Go to original source...
  7. Bello D, Fieno D., Kim RJ, et. al. 2005 Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45:1104-1108. Go to original source...
  8. Schmidt A, Azevedo CF, Cheng A, et al. 2007 Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115:2006-2014. Go to original source...
  9. Zeidan-Shwiri T, Yang Y, Lashevsky I, et al. 2015 Magnetic reson­ ance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia. Heart Rhythm. 2015;12:802-808. doi: 10.1016/j.hrthm.2015.01.007. Go to original source...
  10. Alfakih K, Reid S, Jones T, et al. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol. 2004;14:1813-1822. Go to original source...
  11. Brieger D, Eagle KA, Goodman SG, et al. 2004 Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest. 2004;126:461-469. Go to original source...
  12. Schelbert EB, Cao JJ, Sigurdsson S, et al. 2012 Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012;308:890-896. doi: 10.1001/2012.jama.11089. Go to original source...
  13. Perkins GD, Mcauley DF, Davies S, et al. 2003 Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study. Crit Care. 2003;7: R129-132. Go to original source...
  14. Spiliopoulou C, Papadodima S, Kotakidis N, et al. 2005. Clinical diagnoses and autopsy findings: a retrospective analysis of 252 cases in Greece. Arch Pathol Lab Med. 2005;129:210-214. Go to original source...
  15. Barbier CHE, Bjerner T, Johansson L, et al. 2006. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006;48:765-771. Go to original source...
  16. Schelbert EB, Cao JJ, Sigurdsson S, et al. 2012 Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012;308:890-896. doi: 10.1001/2012.jama.11089 Go to original source...
  17. Rowin EJ, Maron MS. 2016 The role of cardiac MRI in the diagnosis and risk stratification of hypertrophic cardiomyopathy. Arrhythmia & Electrophysiology Review. 2016;5:197-202. DOI: 10.15420/aer.2016:13:3 Go to original source...
  18. Srichai MB, Junor C, Rodriguez LL, et al. Clinical imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am heart J. 2006 Jul 152(1):75-84. Go to original source...
  19. Weinsaft JW, Kim HW, Shah DJ, et al. 2008 Detection of left ventricular thrombus by delayed enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52:148-157. Go to original source...
  20. Durmus T, Schilling R, Doeblin P, et al. 2012 Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine. Invest Radiol. 2012;47:183-188. Go to original source...
  21. Wildgruber M, Stadlbauer T, Rasper M, et al. 2014 Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T. Invest Radiol. 2014;49:728-734. Go to original source...
  22. Wagner M, Schilling R, Doeblin P, et al. 2013 Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gado­ terate meglumine. Eur Radiol. 2013;23:108-114. Go to original source...
  23. Flett AS, Hasleton J, Cook C, et al. 2011 Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4:150-156. Go to original source...
  24. de Jong S, van Veen TAB, de Bakker JMT, van Rijen HVM. 2012 Monitoring cardiac fibrosis: a technical challenge. Neth Heart J. 2012 Jan; 20(1):44-48. Go to original source...